Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder
Asian J Psychiatr
.
2020 Oct:53:102164.
doi: 10.1016/j.ajp.2020.102164.
Epub 2020 May 11.
Authors
Samia Ali
1
,
Zabun Nahar
2
,
Md Rajibur Rahman
3
,
Sardar Mohammad Ashraful Islam
4
,
Mohiuddin Ahmed Bhuiyan
5
,
Md Rabiul Islam
6
Affiliations
1
Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh. Electronic address:
[email protected]
.
2
Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh. Electronic address:
[email protected]
.
3
Department of Psychiatry, Dhaka Medical College, Dhaka, 1000, Bangladesh. Electronic address:
[email protected]
.
4
Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh. Electronic address:
[email protected]
.
5
Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh. Electronic address:
[email protected]
.
6
Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh. Electronic address:
[email protected]
.
PMID:
32446216
DOI:
10.1016/j.ajp.2020.102164
No abstract available
Publication types
Letter
MeSH terms
Depressive Disorder, Major* / drug therapy
Humans
Insulin
Insulin-Like Growth Factor I
Relaxin*
Substances
IGF1 protein, human
Insulin
RLN3 protein, human
Insulin-Like Growth Factor I
Relaxin